wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38525856-143F2ADA-B57C-4982-984A-AEB454B3D098
Q38525856-143F2ADA-B57C-4982-984A-AEB454B3D098
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38525856-143F2ADA-B57C-4982-984A-AEB454B3D098
Strategies to overcome resistance to tyrosine kinase inhibitors in non-small-cell lung cancer.
P2860
Q38525856-143F2ADA-B57C-4982-984A-AEB454B3D098
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38525856-143F2ADA-B57C-4982-984A-AEB454B3D098
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d39f18cec37c8f29fb3d9ccef05d44020b5acdf
P2860
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial.